Taysha gene therapies announces details for oral presentations at the 2025 irsf rett syndrome scientific meeting reviewing recent updates from the tsha-102 clinical program

Recently disclosed clinical cohort data from high (1x10 15 total vg) and low dose (5.7x10 14 total vg) tsha-102 from reveal adolescent/adult and pediatric phase 1/2 trials

TSHA Ratings Summary

TSHA Quant Ranking